An update on the development of concepts, diagnostic criteria, and challenging issues for neuroendocrine neoplasms across different digestive organs

被引:9
作者
Couvelard, Anne [1 ]
Cros, Jerome [1 ]
机构
[1] Univ Paris Cite, Bichat & Beaujon AP HP Hosp, ENETS Ctr Excellence, Dept Pathol, 46 Rue Henri Huchard, F-75018 Paris, France
关键词
Digestive neuroendocrine tumour; Neuroendocrine carcinoma; Classification; Biomarkers; ACINAR-CELL CARCINOMA; GRADE; 3; PROGNOSTIC-FACTORS; PROTEIN-1; INSM1; TUMORS; EXPRESSION; KI-67; G3; SYNAPTOPHYSIN; HETEROGENEITY;
D O I
10.1007/s00428-022-03306-7
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Digestive neuroendocrine neoplasms (NENs) are a group of heterogeneous neoplasms found throughout the digestive tract, with different behaviour and genetic background. In the last few years, nomenclature and WHO/UICC classifications of digestive NENs have changed, and molecular classifications have emerged, especially in pancreatic locations. Increasing patho-molecular details are needed to diagnose the different categories of NEN, including the use of helpful immunohistochemical markers. In this review, we address these topics in three successive chapters. We first briefly review recent updates in classifications, discuss important grading and proliferating issues and advances in the molecular understanding of NEN. Then, we provide an update on diagnosis, including the most important differential diagnoses of NEN, with a focus on high-grade neoplasms and mixed tumours. Finally, we highlight a variety of currently used and next-generation predictive and prognostic biomarkers as well as biomarkers of tumour origin and describe some site specificities of gastrointestinal NEN. We specifically focus on biomarkers available to pathologists with the potential to change the way patients with NEN are diagnosed and treated.
引用
收藏
页码:1129 / 1148
页数:20
相关论文
共 125 条
  • [31] Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: New insights and treatment implications
    Fazio, Nicola
    Milione, Massimo
    [J]. CANCER TREATMENT REVIEWS, 2016, 50 : 61 - 67
  • [32] Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine Carcinomas
    Fraune, Christoph
    Simon, Ronald
    Hube-Magg, Claudia
    Makrypidi-Fraune, Georgia
    Kluth, Martina
    Buescheck, Franziska
    Amin, Tania
    Viol, Fabrice
    Fehrle, Wilfrid
    Dum, David
    Hoeflmayer, Doris
    Burandt, Eike
    Clauditz, Till Sebastian
    Perez, Daniel
    Izbicki, Jakob
    Wilczak, Waldemar
    Sauter, Guido
    Steurer, Stefan
    Schrader, Joerg
    [J]. ENDOCRINE PATHOLOGY, 2020, 31 (02) : 182 - 189
  • [33] Mixed Neuroendocrine Non-Neuroendocrine Neoplasms: A Systematic Review of a Controversial and Underestimated Diagnosis
    Frizziero, Melissa
    Chakrabarty, Bipasha
    Nagy, Bence
    Lamarca, Angela
    Hubner, Richard A.
    Valle, Juan W.
    McNamara, Mairead G.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (01)
  • [34] T-Cell Responses in Merkel Cell Carcinoma: Implications for Improved Immune Checkpoint Blockade and Other Therapeutic Options
    Gehrcken, Laura
    Sauerer, Tatjana
    Schaft, Niels
    Doerrie, Jan
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)
  • [35] Improving the accuracy of gastrointestinal neuroendocrine tumor grading with deep learning
    Govind, Darshana
    Jen, Kuang-Yu
    Matsukuma, Karen
    Gao, Guofeng
    Olson, Kristin A.
    Gui, Dorina
    Wilding, Gregory. E.
    Border, Samuel P.
    Sarder, Pinaki
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [36] Grade Increases in Gastroenteropancreatic Neuroendocrine Tumor Metastases Compared to the Primary Tumor
    Grillo, Federica
    Albertelli, Manuela
    Brisigotti, Maria Pia
    Borra, Tiziana
    Boschetti, Mara
    Fiocca, Roberto
    Ferone, Diego
    Mastracci, Luca
    [J]. NEUROENDOCRINOLOGY, 2016, 103 (05) : 452 - 459
  • [37] Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size
    Hackeng, Wenzel M.
    Brosens, Lodewijk A. A.
    Kim, Joo Young
    O'Sullivan, Roderick
    Sung, You-Na
    Liu, Ta-Chiang
    Cao, Dengfeng
    Heayn, Michelle
    Brosnan-Cashman, Jacqueline
    An, Soyeon
    Morsink, Folkert H. M.
    Heidsma, Charlotte M.
    Valk, Gerlof D.
    Vriens, Menno R.
    van Dijkum, Els Nieveen
    Offerhaus, G. Johan A.
    Dreijerink, Koen M. A.
    Zeh, Herbert
    Zureikat, Amer H.
    Hogg, Melissa
    Lee, Kenneth
    Geller, David
    Marsh, J. Wallis
    Paniccia, Alessandro
    Ongchin, Melanie
    Pingpank, James F.
    Bahary, Nathan
    Aijazi, Muaz
    Brand, Randall
    Chennat, Jennifer
    Das, Rohit
    Fasanella, Kenneth E.
    Khalid, Asif
    McGrath, Kevin
    Sarkaria, Savreet
    Singh, Harkirat
    Slivka, Adam
    Nalesnik, Michael
    Han, Xiaoli
    Nikiforova, Marina N.
    Lawlor, Rita Teresa
    Mafficini, Andrea
    Rusev, Boris
    Corbo, Vincenzo
    Luchini, Claudio
    Bersani, Samantha
    Pea, Antonio
    Cingarlini, Sara
    Landoni, Luca
    Salvia, Roberto
    [J]. GUT, 2022, 71 (05) : 961 - 973
  • [38] Assessment of ARX expression, a novel biomarker for metastatic risk in pancreatic neuroendocrine tumors, in endoscopic ultrasound fine-needle aspiration
    Hackeng, Wenzel M.
    Morsink, Folkert H. M.
    Moons, Leon M. G.
    Heaphy, Christopher M.
    Offerhaus, G. Johan A.
    Dreijerink, Koen M. A.
    Brosens, Lodewijk A. A.
    [J]. DIAGNOSTIC CYTOPATHOLOGY, 2020, 48 (04) : 308 - 315
  • [39] Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN network
    Hadoux, Julien
    Kanaan, Christina
    Durand, Alice
    Hescot, Segolene
    Hautefeuille, Vincent
    Cadiot, Guillaume
    Tauveron, Igor
    Laboureau, Sandrine
    Do Cao, Christine
    Walter, Thomas
    Petorin, Caroline
    Blanchet, Odile
    Jannin, Arnaud
    Gu, Celine
    Faron, Matthieu
    Leteurtre, Emmanuelle
    Rousselet, Marie -Christine
    Zakeyh, Juliette J.
    Marchal, Aude
    Chatelain, Denis
    Beaulaton, Clement
    Hervieu, Valerie
    Ducreux, Michel
    Scoazec, Jean-Yves
    Baudin, Eric
    [J]. EUROPEAN JOURNAL OF CANCER, 2021, 152 : 100 - 115
  • [40] Performance of DAXX Immunohistochemistry as a Screen for DAXX Mutations in Pancreatic Neuroendocrine Tumors
    Hechtman, Jaclyn F.
    Klimstra, David S.
    Nanjangud, Gouri
    Frosina, Denise
    Shia, Jinru
    Jungbluth, Achim A.
    [J]. PANCREAS, 2019, 48 (03) : 396 - 399